-

Consumer Watchdog Attorneys at Hagens Berman Warn John Muir Patients of Potential Overbilling

Law firm says Bay Area patients of any John Muir hospital or emergency room may have been overbilled thousands of dollars for drug tests

SAN FRANCISCO--(BUSINESS WIRE)--Attorneys at consumer-rights law firm Hagens Berman are warning Bay Area residents they may have been wrongfully charged thousands of dollars by John Muir Health hospitals or emergency rooms for drug tests for illicit drug use.

The unexpected charges for drug tests from John Muir Health amount to upwards of $6,000, according to attorneys. Even patients with insurance are left with huge co-pays and deductibles for services they did not request or consent to having performed.

Attorneys at the law firm say patients may have rights to their money back under consumer-protection laws.

If you received large and unexpected charges for a drug test after visiting a John Muir Health location, find out your rights to potential repayment.

Hagens Berman’s representation of consumers has earned it national recognition, and the firm has achieved more than $320 billion in settlements for its clients since its founding.

Your Patient Rights Against Billing Fraud

According to the firm, expensive and unexpected bills for drug tests may constitute fraud, and patients of John Muir hospitals may have consumer rights against these predatory billing practices.

Attorneys say all John Muir Health locations are under investigation, including Concord Medical Center, Walnut Creek Medical Center, Behavioral Health Center, San Ramon Regional Medical Center (Partner Hospital), Urgent Care Centers, Berkeley Urgent Care Center, Brentwood Urgent Care Center, Concord Urgent Care Center, San Ramon Urgent Care Center, Walnut Creek Urgent Care Center and Aspen Surgery Center.

Find out more about the patient billing fraud investigation against John Muir Health.

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation law firm with a tenacious drive for achieving real results for those harmed by corporate negligence and fraud. Since its founding in 1993, the firm’s determination has earned it numerous national accolades, awards and titles of “Most Feared Plaintiff’s Firm,” MVPs and Trailblazers of class-action law. More about the law firm and its successes can be found at www.hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contacts

Ashley Klann
pr@hbsslaw.com
206-268-9318

Hagens Berman


Release Summary
Hagens Berman attorneys warn Bay Area residents they may have been charged thousands by John Muir Health hospitals or ERs for illicit drug use tests.
Release Versions

Contacts

Ashley Klann
pr@hbsslaw.com
206-268-9318

More News From Hagens Berman

Attorneys at Hagens Berman Announce $474M Win in Amitiza Jury Trial Against Takeda

BOSTON--(BUSINESS WIRE)--A class-action lawsuit regarding Amitiza ended today when a jury found Takeda Pharmaceuticals liable for $474 million, according to Hagens Berman....

Hagens Berman: Consumers Sue Amazon Alleging Unlawful Price Hikes to Cover Tariff Costs

SEATTLE--(BUSINESS WIRE)--A consumer-protection lawsuit from Seattle-based law firm Hagens Berman accuses Amazon.com of collecting funds from millions of its customers in response to since invalidated tariffs, passing the buck on rising costs through higher prices. The lawsuit was filed in the U.S. District Court for the Western District of Washington on May 15, 2026, and states that in February 2025 when the Trump administration began imposing tariffs on imported goods under the International...

Hub Group (HUBG) Shares Crater Again Amid Delayed Quarterly Report, Material Misstatements Now Include 2023 and 2024 Financial Reports – Hagens Berman

SAN FRANCISCO--(BUSINESS WIRE)--Investors in Hub Group, Inc. (NASDAQ: HUBG) saw the price of their shares fall $5.24 (-12.5%) on May 12, 2026 after the company announced that it would not timely file its quarterly report for the period ended March 31, 2026 (the “Q1 2026 Form 10-Q”). Hub Group also revealed that investors should no longer rely on its previously filed financial statements for the years ended December 31, 2024 and 2023.The developments, announced on May 12, follow the steep decline...
Back to Newsroom